A new Covid-19 vaccine from Novavax was 89% effective and appeared to offer protection against some variants of the coronavirus in a clinical trial conducted in the UK, the American biotech firm has announced.
Novavax says Covid-19 vaccine is 89% effective in UK trial, but less so in South Africa